SC-38 IDENTIFICATION OF NOVEL THERAPEUTIC TARGETS FOR GLIOBLASTOMA STEM CELLS

The prognosis for patients with glioblastoma (GBM) is poor. Recent evidence suggests that the cells driving GBM malignancy and possibly recurrence are GBM stem cells (GSCs), a small population of GBM cells capable of developing resistance to current therapeutics. To target GSCs, we hypothesized that...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuro Oncol
Asıl Yazarlar: Young, Sarah, Liang, Yanping, Murphy, Susan, Guo, Sujuan, Sheng, Zhi
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2014
Konular:
Abstracts
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4218598/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou275.37
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller